Dermatology Pipeline Database – 2016

Dermatology Pipeline Database – 2016

  • January 2016 •
  • Report ID: 3895215 •
  • Format: PDF
Dermatology Pipeline Highlights Database – 2016, provides most up-to-date information on key pipeline molecules in the global Dermatology market. It covers emerging therapies for Dermatology disorders in active clinical development stages including early and late stage clinical trials. Key indications covered in this report include Impetigo, Atopic Dermatitis, Psoriasis, Erythema multiforme, Alopecia Areata, Acne, and Rosacea. The pipeline data is presented in an excel dashboard with filtering options.
The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

By Indication:
The report presents pipeline by Dermatology indications. Key indications covered in this report include Impetigo, Atopic Dermatitis, Psoriasis, Erythema multiforme, Alopecia Areata, Acne, and Rosacea.

By Clinical Trial Stages:
The report provides Dermatology pipeline molecules by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

By Drug Mechanism Classes:
The report provides Dermatology pipeline molecules by their dominant drug mechanism class. This helps executives categorize molecules based on their drug class and also assess the strengths and weaknesses of compounds.

By Company:
The report provides Dermatology pipeline molecules by the developing company and the partnered company.

SUMMARY:
- Dermatology Pipeline by Indication
- Dermatology Pipeline by Clinical Trial Phase
- Dermatology Pipeline by Drug Mechanism Classes
- Dermatology Pipeline by Company